Home
Live Updates
Sustained Serum Urate Reduction for Gout Patients Observed with AR882 : comparemela.com
Sustained Serum Urate Reduction for Gout Patients Observed with AR882
In this data shown at ACR 2023, the URAT1 inhibitor known as AR882 showed promising phase 2b data for patients with gout.
Related Keywords
San Diego ,
California ,
United States ,
Robertt Keenan ,
,
Energy Computer Tomography ,
American College Of Rheumatology Convergence ,
Trial Using Dual Energy Computed Tomography ,
American College Of Rheumatology ,
American College ,
Dual Energy Computer Tomography ,
Arthrosi Therapeutics ,
Chronic Gouty Arthritis ,
Subcutaneous Tophi ,
Proof Of Concept Trial Using Dual Energy Computed ,
Rheumatology Convergence ,
Gout ,
Rheumatology ,
Racr ,
comparemela.com © 2020. All Rights Reserved.